October 23, 2013
A former Bristol-Myers Squibb Co. executive on Wednesday was sentenced in New Jersey federal court to 366 days in prison for insider trading after admitting to purchasing stock options in a biotechnology company he knew BMS was preparing to acquire.
June 10, 2013
A former Bristol-Myers Squibb Co. executive pled guilty Monday to securities fraud charges in New Jersey federal court, admitting he committed insider trading by purchasing stock options in a biotechnology company after learning BMS planned to acquire it.